Nahdi logs 9% rise in 2022 profit to SAR 887.8 mln; Q4 at SAR 128 mln

20/03/2023 Argaam Exclusive

View other reports

Nahdi Medical Co. reported a rise of 9% in 2022 net profit to SAR 887.8 million, from SAR 812.5 million a year earlier.

Financials (M)

Item	2021	2022	Change‬
Revenues	8,066.22	8,616.19	6.8 %
Gross Income	3,304.68	3,545.39	7.3 %
Operating Income	847.88	975.52	15.1 %
Net Income	812.53	887.81	9.3 %
Average Shares	130.00	130.00	-
EPS (Riyals)	6.25	6.83	9.3 %

The medical services provider cited a 6.8% year-on-year (YoY) rise in revenue, primarily on the pharma segment growth and improved religious tourism, which normalized to the pre-pandemic levels at the two Holy Mosques in Makkah and Madinah.

Gross profit jumped 6.5% YoY on sales growth. Gross profit margins reached 40.9%, maintaining the same level of 2021.

On the other hand, operating expenses increased by 4.6% YoY, below the top-line growth. The increase was mainly attributed to support the business growth. The net balance of operating expenses and other operating revenue increased by 5.6% YoY in the 12-month period.

Current Quarter Comparison (M)

Compared With The

Item	Q4 2021	Q4 2022	Change‬
Revenues	1,973.23	2,138.24	8.4 %
Gross Income	807.21	856.31	6.1 %
Operating Income	99.44	148.89	49.7 %
Net Income	143.23	127.99	(10.6 %)
Average Shares	130.00	130.00	-
EPS (Riyals)	1.10	0.98	(10.6 %)

Item	Q3 2022	Q4 2022	Change‬
Revenues	2,158.98	2,138.24	(1.0 %)
Gross Income	911.06	856.31	(6.0 %)
Operating Income	271.48	148.89	(45.2 %)
Net Income	253.81	127.99	(49.6 %)
Average Shares	130.00	130.00	-
EPS (Riyals)	1.95	0.98	(49.6 %)

The fourth-quarter net profit dropped 11% to SAR 128 million, from SAR 143.23 million in Q4 2021.

Compared to the previous quarter, Q4 net profit fell by 49.6% from SAR 253.81 million.

Shareholders’ equity, after minority interest, rose to SAR 2.24 billion as of Dec. 31, 2022, from SAR 1.60 billion a year earlier.

View More Financial Results

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

×